Regenerative medicine – breaking down the next paradigm
- February 8, 2018
- By Dr. Robert A. Eslinger, D.O., H.M.D. | Reno Integrative Medical Center
- Categories: Alternative Medicine, Healthy Living, Sustainability
Regenerative therapies that go way beyond just “managing” symptoms or chronic diseases are coming to the market.
These therapies aid and supplement the natural healing mechanisms of the body, rather than blocking or covering up symptoms. Cell-based therapies employ the activation of stem cells to stimulate renewal of cells and tissues that have been damaged by injury, disease or age.
The rapid expansion of scientific knowledge offers immense promise for continuing advances in this field of medicine, which holds vast potential and transformative promise for healing from both injuries and chronic degenerative diseases.
Stem cells are undifferentiated basic building blocks of life that are found in the body’s tissues, organs and systems and are able to differentiate into various kinds of cells and tissues.
The ability to regenerate parts of the human body confirms the paradigm shift that is taking place in the practice of medicine.
There is no ethical or moral dilemma in collecting these cells, because they are derived from birth tissue donated by mothers delivering healthy live babies by Caesarean section. These cells include minimally manipulated material from the amniotic membrane, umbilical cord tissue and blood, and they are of the highest quality.
The extraction process maximizes the bioactive cellular messaging components for optimal tissue regenerative benefits.
Our bodies use stem cells to repair themselves; however, injury, disease or the aging process often inhibits our own stem cells. These therapies provide potential successful treatment for the cellular breakdown caused by inflammation and tissue damage resulting in pain syndromes, as well as certain systemic conditions, overall disease and dysfunction.
The body’s immune system is unable to recognize umbilical cord derived stem cells as foreign, and therefore, they are not rejected by it. As a matter of fact, allogeneic (not the patient’s own) stem cells are approved to treat graft vs. host (immune system rejection) disease in Canada and New Zealand.
Stem cell therapy shows promise in treating everything from eczema to congestive heart failure, Parkinson’s, MS, Rheumatoid and Osteoarthritis, and COPD, as well as preventing damage from a heart attack.
The company that uses a proprietary process to provide these cells is located in Utah, not some third world country. They operate under very strict guidelines for the processing of human cells that are overseen by the FDA.
These therapies are available today not some nebulous time off in the future.
Dr. Robert A. Eslinger, D.O., H.M.D., specializes in cancer and chronic disease and is an integrative cancer doctor licensed to practice in California, Idaho and Nevada. He is head doctor at the Reno Integrative Medical Center. Visit www.renointegrative.com or call 775-829-1009 to learn more.
- Riordan, PA, PhD, Neil H. — “Stem Cell Therapy – A Rising Tide,” 2016
- Ichim, Solano, Lara, Paz Rodriguez, Cristea, Minev, Ramos, Woods, Murphy, Alexandrescu, Patel, Riordan — “Combination of Stem Cell Therapy for Heart Failure,” International Archives of Medicine, 2010.